PL3497440T3 - Sposób chromatograficzny oznaczania ilościowego niejonowego środka powierzchniowo czynnego w kompozycji zawierającej niejonowy środek powierzchniowo czynny i polipeptyd - Google Patents

Sposób chromatograficzny oznaczania ilościowego niejonowego środka powierzchniowo czynnego w kompozycji zawierającej niejonowy środek powierzchniowo czynny i polipeptyd

Info

Publication number
PL3497440T3
PL3497440T3 PL17755627.1T PL17755627T PL3497440T3 PL 3497440 T3 PL3497440 T3 PL 3497440T3 PL 17755627 T PL17755627 T PL 17755627T PL 3497440 T3 PL3497440 T3 PL 3497440T3
Authority
PL
Poland
Prior art keywords
ionic surfactant
quantifying
polypeptide
composition
chromatography method
Prior art date
Application number
PL17755627.1T
Other languages
English (en)
Inventor
Mary MONTTI
Richard L. Beardsley
Michael S. CHINN
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3497440T3 publication Critical patent/PL3497440T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847—Multimodal interactions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicinal Preparation (AREA)
PL17755627.1T 2016-08-15 2017-08-14 Sposób chromatograficzny oznaczania ilościowego niejonowego środka powierzchniowo czynnego w kompozycji zawierającej niejonowy środek powierzchniowo czynny i polipeptyd PL3497440T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662375373P 2016-08-15 2016-08-15
PCT/US2017/046725 WO2018035025A1 (en) 2016-08-15 2017-08-14 Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide

Publications (1)

Publication Number Publication Date
PL3497440T3 true PL3497440T3 (pl) 2025-08-04

Family

ID=59687053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17755627.1T PL3497440T3 (pl) 2016-08-15 2017-08-14 Sposób chromatograficzny oznaczania ilościowego niejonowego środka powierzchniowo czynnego w kompozycji zawierającej niejonowy środek powierzchniowo czynny i polipeptyd

Country Status (17)

Country Link
US (2) US11333644B2 (pl)
EP (1) EP3497440B1 (pl)
JP (1) JP7286536B2 (pl)
KR (1) KR102617148B1 (pl)
CN (2) CN109716127B (pl)
AR (1) AR109343A1 (pl)
AU (2) AU2017312540B2 (pl)
BR (1) BR112019002979B1 (pl)
ES (1) ES3034020T3 (pl)
HR (1) HRP20250718T1 (pl)
HU (1) HUE071741T2 (pl)
IL (1) IL264582B (pl)
MX (2) MX2019001572A (pl)
PL (1) PL3497440T3 (pl)
SG (1) SG11201901228QA (pl)
TW (1) TWI775770B (pl)
WO (1) WO2018035025A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210139387A1 (en) * 2016-01-19 2021-05-13 Genebiologics, Llc Production of Arginine-Rich Proteins from Wastewater and Use as a Fertilizer
JP7286536B2 (ja) 2016-08-15 2023-06-05 ジェネンテック, インコーポレイテッド 非イオン性サーファクタント及びポリペプチドを含む組成物中の非イオン性サーファクタントを定量するためのクロマトグラフィー法
TWI870390B (zh) * 2019-02-27 2025-01-21 法商賽諾菲公司 以具內標之lc-ms於樣品中進行聚山梨醇酯定量之方法
WO2020211584A1 (zh) * 2019-04-19 2020-10-22 海正生物制药有限公司 组合物中泊洛沙姆188的检测方法
CN114981286B (zh) 2019-05-03 2026-02-13 豪夫迈·罗氏有限公司 降低从纯化平台获得的组合物中酶水解活性速率的方法
EP4090666A1 (en) 2020-01-15 2022-11-23 F. Hoffmann-La Roche AG Methods to decrease impurities from recombinant protein manufacturing processes
AU2021371309A1 (en) 2020-10-30 2023-05-18 Genentech, Inc. Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate
CN116964068A (zh) 2021-02-24 2023-10-27 豪夫迈·罗氏有限公司 深度过滤器的再生和多次使用
KR102283871B1 (ko) * 2021-03-02 2021-08-02 한국원자력연구원 크로마토그래피를 이용한 무담체 홀뮴-166의 분리 방법, 분리 장치 및 이에 의하여 분리된 무담체 홀뮴-166
AU2022429920A1 (en) * 2021-12-31 2024-07-25 Kashiv Biosciences, Llc A process for separation and quantification of non-ionic surfactant
WO2024145244A1 (en) * 2022-12-30 2024-07-04 Eli Lilly And Company Methods for measuring levels of polysorbate(s)
WO2026062617A1 (en) * 2024-09-23 2026-03-26 Janssen Pharmaceuticals, Inc. Methods for detection and quantification of surfactants

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61141719A (ja) * 1984-08-22 1986-06-28 キュノ、インコ−ポレ−テッド 変性ポリペプチド支持体
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
DE3850542T2 (de) 1987-09-23 1994-11-24 Bristol Myers Squibb Co Antikörper-Heterokonjugate zur Töting von HIV-infizierten Zellen.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
EP0479909B1 (en) 1989-06-29 1996-10-30 Medarex, Inc. Bispecific reagents for aids therapy
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
ATE255131T1 (de) 1991-06-14 2003-12-15 Genentech Inc Humanisierter heregulin antikörper
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
CA2116774C (en) 1991-09-19 2003-11-11 Paul J. Carter Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
FI941572L (fi) 1991-10-07 1994-05-27 Oncologix Inc Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
WO1993016185A2 (en) 1992-02-06 1993-08-19 Creative Biomolecules, Inc. Biosynthetic binding protein for cancer marker
ATE244763T1 (de) 1992-02-11 2003-07-15 Cell Genesys Inc Erzielen von homozygotem durch zielgerichtete genetische ereignisse
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
EP0656064B1 (en) 1992-08-17 1997-03-05 Genentech, Inc. Bispecific immunoadhesins
DE69303494T2 (de) 1992-11-13 1997-01-16 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
JPH0943218A (ja) * 1995-08-04 1997-02-14 Kao Corp 非イオン界面活性剤の分析方法
AU3454899A (en) * 1998-03-30 1999-10-18 Cell Therapeutics, Inc. Methods of separation and detection
IL127127A0 (en) 1998-11-18 1999-09-22 Peptor Ltd Small functional units of antibody heavy chain variable regions
ES2376454T3 (es) 2000-12-22 2012-03-14 Grad, Carole, Legal Representative Of Howard, Kaplan Librer�?as de expresión en fago de fragmentos vh humanos.
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
GB0310347D0 (en) * 2003-05-07 2003-06-11 Delta Biotechnology Ltd Assay
SI1639011T1 (sl) 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
EP1705482B1 (en) 2003-12-11 2017-09-27 Kazuhiro Imai Method of detection, separation and identification for expressed trace protein/peptide
WO2006031370A2 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
ES2579805T3 (es) 2004-09-23 2016-08-16 Genentech, Inc. Anticuerpos y conjugados modificados por ingeniería genética con cisteína
JP2008524393A (ja) * 2004-12-21 2008-07-10 バクスター・インターナショナル・インコーポレイテッド ポリアルコキシスルホネート表面改変因子
US7241586B2 (en) * 2005-02-17 2007-07-10 Medtronic Minimed, Inc. Polypeptide formulations and methods for making, using and characterizing them
WO2010141426A1 (en) 2009-06-01 2010-12-09 Waters Technologies Corporation Hybrid material for chromatographic separations
US20120294866A1 (en) * 2010-01-19 2012-11-22 F. Hoffmann-La Roche Ag Pharmaceutical formulation for proteins
EP4492053A3 (en) 2010-05-25 2025-03-19 F. Hoffmann-La Roche AG Methods of purifying polypeptides
JP5193266B2 (ja) 2010-11-16 2013-05-08 株式会社ミノファーゲン製薬 生薬由来成分の高感度定量方法
CA2843197A1 (en) * 2011-07-29 2013-02-07 Eleven Biotherapeutics, Inc. Purified proteins
EP3527274B1 (en) * 2011-11-02 2025-12-24 F. Hoffmann-La Roche AG Overload and elute chromatography
EP2852828B1 (en) * 2012-05-23 2016-04-06 GlaxoSmithKline Biologicals S.A. Method for determining a concentration of a polysorbate species in a mixture
JP7286536B2 (ja) 2016-08-15 2023-06-05 ジェネンテック, インコーポレイテッド 非イオン性サーファクタント及びポリペプチドを含む組成物中の非イオン性サーファクタントを定量するためのクロマトグラフィー法

Also Published As

Publication number Publication date
SG11201901228QA (en) 2019-03-28
JP7286536B2 (ja) 2023-06-05
EP3497440B1 (en) 2025-04-30
KR20190051977A (ko) 2019-05-15
US11680931B2 (en) 2023-06-20
IL264582A (en) 2019-02-28
MX2019001572A (es) 2019-08-29
KR102617148B1 (ko) 2023-12-26
CN109716127A (zh) 2019-05-03
CN115598231B (zh) 2025-11-18
IL264582B (en) 2022-04-01
TWI775770B (zh) 2022-09-01
AU2022291517B2 (en) 2024-12-12
US20190178859A1 (en) 2019-06-13
CN109716127B (zh) 2022-06-14
EP3497440A1 (en) 2019-06-19
WO2018035025A1 (en) 2018-02-22
EP3497440C0 (en) 2025-04-30
CA3033737A1 (en) 2018-02-22
AU2022291517A1 (en) 2023-02-02
HUE071741T2 (hu) 2025-09-28
BR112019002979B1 (pt) 2023-10-03
US11333644B2 (en) 2022-05-17
AU2017312540A1 (en) 2019-02-28
TW201809658A (zh) 2018-03-16
HRP20250718T1 (hr) 2025-08-15
JP2019530857A (ja) 2019-10-24
AU2017312540B2 (en) 2023-02-02
ES3034020T3 (en) 2025-08-12
MX2024006922A (es) 2024-06-20
BR112019002979A2 (pt) 2019-07-09
CN115598231A (zh) 2023-01-13
US20230077255A1 (en) 2023-03-09
AR109343A1 (es) 2018-11-21

Similar Documents

Publication Publication Date Title
IL264582B (en) Chromatography method for quantifying a non-ionic surfactant in a preparation containing the non-ionic surfactant and a polypeptide
GB2554321B (en) Stationary interface control and method for using the same
SG11201709768YA (en) System and method for automatically inspecting surfaces
HUE042338T2 (hu) Rendszer és eljárás csiszolható anyag javítására
GB2541311B (en) Method comprising surfactant formulation for reduced and delayed adsorption
ZA201708452B (en) Automated rebooking system and method for airlines
ZA201801830B (en) Matting agents and method for the production thereof
SG10201504093UA (en) Methods and systems for determining merchant satisfaction
SG11201607461PA (en) Polishing composition and polishing method using the same
GB201702856D0 (en) Method in continuous chromatography
PL3359515T3 (pl) Środek zwilżający i przeciwpieniący
HUE047391T2 (hu) Összekötõelem és eljárás legalább két munkadarab összekötésére
HUE053092T2 (hu) Eljárás és berendezés helymeghatározáshoz
PL3478900T3 (pl) Połączenie do podłóg w pasach
PL3448555T3 (pl) Stała kompozycja oczyszczająca, sposób jej otrzymywania i jej zastosowania
SG11201801589SA (en) Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same
EP3268042C0 (en) COMPOSITION CONTAINING AN ANTI-TNF-ALPHA POLYPEPTIDE AND USE
PL3042743T3 (pl) Sposób obróbki przedmiotów obrabianych, w szczególności taśm obrzeżowych, i urządzenie do realizacji sposobu
SG11201605747PA (en) Solid fat composition and method for manufacturing the same
IL259598A (en) Screed fastener and methods for using the same
SG10202010606YA (en) Method for reducing the trisulfide level in proteins
GB201700116D0 (en) Method and composition
HUE059855T2 (hu) Paraffinokat tartalmazó készítmény és eljárás annak elõállítására
TWI562571B (en) Digital demodulator and the method thereof
IL264380A (en) Increased fertility in cattle breeds